Targeting papain-like protease for broad-spectrum coronavirus inhibition
暂无分享,去创建一个
Jian-Piao Cai | Cuiting Luo | J. Chan | K. Yuen | H. Chu | Shuofeng Yuan | D. Jin | Zhen Qin | Z. Ye | Menglong Hu | Lei Wen | F. Yin | S. Cui | B. Qin | Jianli Cao | Xiaopan Gao | J. Tsang | Ronghui Liang | Kaiming Tang | C. Chan | Ren Sun | Peng Luo | Yaoqiang Huang | Hin Chu
[1] Jian-Piao Cai,et al. Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity , 2021, Science Advances.
[2] Junhao Hu,et al. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2 , 2021, Cell Chemical Biology.
[3] L. Guddat,et al. High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors , 2021, Protein & Cell.
[4] Ronald A. Li,et al. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 , 2021, Nature.
[5] Wenjie Zhu,et al. The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery , 2021, Nature communications.
[6] Benjamin A. Shoemaker,et al. PubChem in 2021: new data content and improved web interfaces , 2020, Nucleic Acids Res..
[7] J. Chan,et al. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters , 2020, Nature Microbiology.
[8] Meitian Wang,et al. Crystal structure of SARS-CoV-2 papain-like protease , 2020, Acta Pharmaceutica Sinica B.
[9] Gerbrand J. van der Heden van Noort,et al. Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2 , 2020, The EMBO journal.
[10] Cooper A. Taylor,et al. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors , 2020, Nature Communications.
[11] K. Yuen,et al. Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε , 2020, The Journal of Immunology.
[12] K. To,et al. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target , 2020, Science Advances.
[13] G. Hummer,et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity , 2020, Nature.
[14] C. Svendsen,et al. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection , 2020, Cell Reports Medicine.
[15] D. Agard,et al. A molecular pore spans the double membrane of the coronavirus replication organelle , 2020, Science.
[16] T. Akkoç,et al. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2. , 2020, Advances in experimental medicine and biology.
[17] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[18] K. To,et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Karthik Srinivasan,et al. Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease , 2019, Antiviral Research.
[20] Yi Guan,et al. Two Methods for Mapping and Visualizing Associated Data on Phylogeny Using Ggtree. , 2018, Molecular biology and evolution.
[21] Z. Mu,et al. Structural Insight Into Conformational Changes Induced by ATP Binding in a Type III Secretion-Associated ATPase From Shigella flexneri , 2018, Front. Microbiol..
[22] Sudhir Kumar,et al. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.
[23] Fabian Sievers,et al. Clustal Omega for making accurate alignments of many protein sequences , 2018, Protein science : a publication of the Protein Society.
[24] S. Perlman,et al. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice , 2017, Proceedings of the National Academy of Sciences.
[25] Roland Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[26] Jie Zhou,et al. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication. , 2016, The Journal of antimicrobial chemotherapy.
[27] Susanna K. P. Lau,et al. Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease , 2015, Clinical Microbiology Reviews.
[28] A. Mesecar,et al. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds , 2014, Antiviral Research.
[29] A. Mesecar,et al. Catalytic Function and Substrate Specificity of the Papain-Like Protease Domain of nsp3 from the Middle East Respiratory Syndrome Coronavirus , 2014, Journal of Virology.
[30] Michael W. Wilson,et al. X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases , 2014, Journal of medicinal chemistry.
[31] E. Arutyunova,et al. ISG15 Arg151 and the ISG15-Conjugating Enzyme UbE1L Are Important for Innate Immune Control of Sindbis Virus , 2008, Journal of Virology.
[32] Wentao Fu,et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication , 2008, Proceedings of the National Academy of Sciences.
[33] Zhongbin Chen,et al. The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity , 2005, Journal of Virology.